Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 110 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05733091
- Conditions
- Neoplasms, Tumors
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
HP Pyruvate MRI in Cancers
NCT05697406
- Conditions
- Image, Neoplasms, Tumors, +1 more
- Locations
-
- University of Maryland Medical Center Baltimore, Maryland, United States
NCT04341181
- Conditions
- Cancer, Neoplasia, Neoplasms, +1 more
- Locations
-
- Aalborg University Hospital Aalborg, Denmark
- Aarhus University Hospital Aarhus, Denmark
- Rigshospitalet Copenhagen, Denmark
- Herlev Hospital Herlev, Denmark
Recruiting
Cohort of Tumors With POLE/D1 Mutation
NCT05103969
- Conditions
- Neoplasms, POLD1 Gene Mutation, POLE Exonuclease Domain Mutation, +1 more
- Locations
-
- CHU -hopital Rangeuil Toulouse, France
Recruiting
The Drug Rediscovery Protocol (DRUP Trial)
NCT02925234
- Conditions
- Cancer, Neoplasia, Neoplasm, +2 more
- Locations
-
- Noordwest ziekenhuisgroep Alkmaar (NWZ) Alkmaar, Netherlands
- Ziekenhuisgroep Twente Almelo, Netherlands
- Meander medisch centrum Amersfoort, Netherlands
- Netherlands Cancer Institute Amsterdam, Netherlands
Recruiting
XACT ACE Observational Registry
NCT04950959
- Conditions
- Neoplasms, Tumors
- Locations
-
- Lahey Hospital and Medical Center Burlington, Massachusetts, United States
NCT02275910
- Conditions
- Neoplasms, Tumors
- Locations
-
- Eisai Trial Site #1 Nagoya, Aichi-ken, Japan
- Eisai Trial Site #1 Kashiwa, Chiba, Japan
- Eisai Trial Site #1 Matsuyama, Ehime, Japan
- Eisai Trial Site #1 Sapporo, Hokkaido, Japan
NCT06945432
- Conditions
- FAPI, FDG PET/CT, Neoplasms, +2 more
- Locations
-
- The Second Hospital of Lanzhou University Lanzhou, Gansu, China
Completed
CDK4/6 Tumor, Abemaciclib, Paclitaxel
NCT04594005
- Conditions
- Neoplasms, Tumors
- Locations
-
- Severance Hospital Seoul, South Korea
NCT03760081
- Conditions
- Incurable Platinum Refractory Germ Cell Tumors, Neoplasms, Tumors
- Locations
-
- Indiana University Simon Cancer Center Indianapolis, Indiana, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Abramson Cancer Center University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00400023
- Conditions
- Neoplasms, Tumors
- Locations
-
- Premiere Oncology of Arizona Scottsdale, Arizona, United States
- Premiere Oncology, A Medical Corporation Santa Monica, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
NCT00113113
- Conditions
- Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
- The Center for Cancer Care and Research St Louis, Missouri, United States
Completed
A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors
NCT02549937
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +12 more
- Locations
-
- City of Hope Comprehensive Cancer Center Los Angeles, California, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
- SCRI at HealthONE Denver, Colorado, United States
- Florida Cancer Specialists Sarasota, Florida, United States
NCT02831556
- Conditions
- Abdominal Injuries, Adnexal Diseases, Aneurysm, +60 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
NCT01409135
- Conditions
- Medical Oncology, Neoplasms, Tumors
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- University of Colorado, Denver-Aurora Aurora, Colorado, United States
- Emory University Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors
NCT02501096
- Conditions
- Neoplasms, Tumors
- Locations
-
- Alaska Clinical Research Center Anchorage, Alaska, United States
- Arizona Oncology Associates Oro Valley, Arizona, United States
- Arizona Oncology Associates, PC - HOPE, Site #1 Tucson, Arizona, United States
- Arizona Oncology Associates, PC - HOPE, Site #2 Tucson, Arizona, United States
NCT02646852
- Conditions
- Cancer, Neoplasms, Tumors
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT02432274
- Conditions
- Differentiated Thyroid Cancer (DTC), Neoplasms, Neoplasms by Histologic Type, +7 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
- CHU Strasbourg - Hopital Hautepierre Strasbourg, Bas Rhin, France
- Centre Oscar Lambret Lille Lille, Rhone, France
- Centre Leon Berard Lyon, Rhone, France
NCT01444404
- Conditions
- Advanced Malignancy, Advanced Solid Tumors, Cancer, +4 more
- Locations
-
- Research Site Philadelphia, Pennsylvania, United States
- Research Site Greenville, South Carolina, United States
- Research Site San Antonio, Texas, United States
Completed
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
NCT00807859
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +16 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Boca Raton, Florida, United States
- Research Site Iowa City, Iowa, United States
- Research Site Boston, Massachusetts, United States